FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dawn Hershman

Research Profile

Disorders

Activities & Behaviors

SEER Program

Procedures

Geographic Areas

United States

Concepts & Ideas

Chemicals & Drugs

Antineoplastic Agents

Living Beings

Co-author Network

Publications

TOP 3
Dawn Hershman; Ramona Jayasena; Kevin Kalinsky; Grace Kranwinkel; Matthew Maurer; Alfred I Neugut; Wei-Yann Tsai; Danielle Awad; Lois Brafman; Heather Greenlee; Katherine D Crew
Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors.
Dawn Hershman; K Kalinsky; Y S Lu; Alfred I Neugut; C A Richards; E T Wilde; Jeffrey A Ascherman; Jason D Wright
Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer.
Katherine D Crew; Heather Greenlee; Aqeel Ahmed; Banu Arun; Therese B Bevers; Powel Brown; Jenny Chang; Terri L Cornelison; Hanina Hibshoosh; Clifford Hudis; Scott M Lippman; Heather L McArthur; Mothaffar Rimawi; Regina M Santella; Mary Beth Terry; Lana Vornik; Antai Wang; Dawn Hershman
Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dawn Hershman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Dawn Hershman; Ramona Jayasena; Kevin Kalinsky; Grace Kranwinkel; Matthew Maurer; Alfred I Neugut; Wei-Yann Tsai; Danielle Awad; Lois Brafman; Heather Greenlee; Katherine D Crew
Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors.
Breast cancer research and treatment 2013;138(3):795-806.
2012: Dawn Hershman; K Kalinsky; Y S Lu; Alfred I Neugut; C A Richards; E T Wilde; Jeffrey A Ascherman; Jason D Wright
Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer.
Breast cancer research and treatment 2012;136(2):535-45.
2012: Katherine D Crew; Heather Greenlee; Aqeel Ahmed; Banu Arun; Therese B Bevers; Powel Brown; Jenny Chang; Terri L Cornelison; Hanina Hibshoosh; Clifford Hudis; Scott M Lippman; Heather L McArthur; Mothaffar Rimawi; Regina M Santella; Mary Beth Terry; Lana Vornik; Antai Wang; Dawn Hershman
Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.
Cancer prevention research (Philadelphia, Pa.) 2012;5(9):1144-54.
2012: S M Lee; John P Leonard; P Martin; Dawn Hershman; Y K Cheung
Toxicity burden score: a novel approach to summarize multiple toxic effects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(2):537-41.
2011: Jason D Wright; Donna L Buono; Jennifer Malin; Alfred I Neugut; Wei Y Tsai; Elizabeth T Wilde; Dawn Hershman
Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(25):3408-18.
2011: Dawn Hershman; Theresa H. Shao; Lawrence H Kushi; Donna Buono; Wei-Yann Tsai; Louis Fehrenbacher; Marilyn Kwan; Scarlett Lin Gomez; Alfred I Neugut
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Breast cancer research and treatment 2011;126(2):529-37.
2011: Dawn Hershman; Louis H Weimer; Antai Wang; Grace Kranwinkel; Lois Brafman; Deborah Fuentes; Danielle Awad; Katherine D Crew
Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy.
Breast cancer research and treatment 2011;125(3):767-74.
2011: Victor R Grann; Priya R Patel; Judith S Jacobson; Ellen Warner; Daniel F Heitjan; Maxine Ashby-Thompson; Dawn Hershman; Alfred I Neugut
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers.
Breast cancer research and treatment 2011;125(3):837-47.
2010: Abby B Siegel; Shuang Wang; Judith S Jacobson; Dawn Hershman; Emerson A Lim; Jeanette Yu; Lauren Ferrante; Kalpana M Devaraj; Helen Remotti; Shannon Scrudato; Karim Halazun; Jean Emond; Lorna Dove; Robert S Brown; Alfred I Neugut
Obesity and microvascular invasion in hepatocellular carcinoma.
Cancer investigation 2010;28(10):1063-9.
2010: Dawn Hershman; Lawrence H Kushi; Theresa H. Shao; Donna Buono; Aaron Kershenbaum; Wei-Yann Tsai; Louis Fehrenbacher; Sunita Miles; Scarlett Lin Gomez; Alfred I Neugut
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4120-8.
2010: Felice A Tager; Paula S McKinley; Freya Schnabel; Mahmoud El-Tamer; Ying Keun K Cheung; Yixin Fang; Claire R Golden; Margery E Frosch; Ulya Habif; Margaret M Mulligan; Ivy S Chen; Dawn Hershman
The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
Breast cancer research and treatment 2010;123(1):25-34.
2010: Bo Yu; Nataki Douglas; Michel J Ferin; Gary S Nakhuda; Katherine Crew; Rogerio A Lobo; Dawn Hershman
Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy.
Cancer 2010;116(9):2099-105.
2010: Jeanette C Yu; Alfred I Neugut; Shuang Wang; Judith S Jacobson; Lauren Ferrante; Vandana Khungar; Emerson Lim; Dawn Hershman; Robert S Brown; Abby B Siegel
Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma.
Cancer 2010;116(7):1801-9.
2010: Joshua Strauss; Dawn Hershman; Donna Buono; Russell McBride; Sean Clark-Garvey; Shermian A Woodhouse; Julian A Abrams; Alfred I Neugut
Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival.
International journal of radiation oncology, biology, physics 2010;76(5):1404-12.
2010: Katherine D Crew; Jillian L Capodice; Heather Greenlee; Lois Brafman; Deborah Fuentes; Danielle Awad; Wei Yann Tsai; Dawn Hershman
Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(7):1154-60.
2010: Dennis Kuo; Stephanie V Blank; Paul J Christos; Mimi Y Kim; Thomas A Caputo; Bhavana Pothuri; Dawn Hershman; Noah Goldman; Percy Ivy; Carolyn D Runowicz; Franco Muggia; Gary L Goldberg; Mark Einstein
Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study.
Gynecologic oncology 2010;116(3):442-6.
2010: Dawn Hershman; Donald J McMahon; Katherine D Crew; Theresa H. Shao; Serge Cremers; Lois Brafman; Danielle Awad; Elizabeth Shane
Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment.
The Journal of clinical endocrinology and metabolism 2010;95(2):559-66.
2010: Victor R Grann; Priya Patel; Anubha Bharthuar; Judith S Jacobson; Ellen Warner; Kristin Anderson; Eiran Warner; Wei-Yann Tsai; Kimberly A Hill; Alfred I Neugut; Dawn Hershman
Breast cancer-related preferences among women with and without BRCA mutations.
Breast cancer research and treatment 2010;119(1):177-84.
2009: Dawn Hershman; Donna L Buono; Jennifer Malin; Russell McBride; Wei-Yann Tsai; Alfred I Neugut
Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer.
Journal of the National Cancer Institute 2009;101(23):1633-41.
2009: Olivia S Fu; Katherine D Crew; Judith S Jacobson; Heather Greenlee; Gary Yu; Julie Campbell; Yvette Ortiz; Dawn Hershman
Ethnicity and persistent symptom burden in breast cancer survivors.
Journal of cancer survivorship : research and practice 2009;3(4):241-50.
2009: Julian A Abrams; Donna L Buono; Joshua Strauss; Russell B McBride; Dawn Hershman; Alfred I Neugut
Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly.
Cancer 2009;115(21):4924-33.
2009: Dawn Hershman; Dana Hurley; Mitchell D Wong; Vicki A Morrison; Jennifer L Malin
Impact of primary prophylaxis on febrile neutropenia within community practices in the US.
Journal of medical economics 2009;12(3):203-10.
2009: Dawn Hershman; Donna Buono; Russell B McBride; Wei-Yann Tsai; Alfred I Neugut
Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women.
Cancer 2009;115(17):3848-57.
2009: Kathy S Albain; Joseph M Unger; John J Crowley; Charles A Coltman; Dawn Hershman
Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
Journal of the National Cancer Institute 2009;101(14):984-92.
2009: Heather Greenlee; Marilie D Gammon; Page E Abrahamson; Mia M. Gaudet; Mary Beth Terry; Dawn Hershman; Manisha Desai; Susan L Teitelbaum; Alfred I Neugut; Judith S Jacobson
Prevalence and predictors of antioxidant supplement use during breast cancer treatment: the Long Island Breast Cancer Study Project.
Cancer 2009;115(14):3271-82.
2009: Katherine D Crew; Marilie D Gammon; Susan Scott; Dawn Hershman; Serge Cremers; Elzbieta Dworakowski; Elizabeth Shane; Mary Beth Terry; Manisha Desai; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Association between plasma 25-hydroxyvitamin D and breast cancer risk.
Cancer prevention research (Philadelphia, Pa.) 2009;2(6):598-604.
2009: Heather Greenlee; Dawn Hershman; Judith S Jacobson
Use of antioxidant supplements during breast cancer treatment: a comprehensive review.
Breast cancer research and treatment 2009;115(3):437-52.
2009: Dawn Hershman; Donna Buono; Judith S Jacobson; Russell B McBride; Wei-Yann Tsai; Kathie-Ann Joseph; Alfred I Neugut
Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer.
Annals of surgery 2009;249(5):828-33.
2009: Katherine D Crew; Elizabeth Shane; Serge Cremers; Donald J McMahon; Dinaz Irani; Dawn Hershman
High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2151-6.
2009: Dawn Hershman; Joseph M Unger; William E Barlow; Laura F Hutchins; Silvana Martino; C Kent Osborne; Robert B Livingston; Kathy S Albain
Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2157-62.
2009: Joseph A Sparano; Stacy Moulder; Aslamuzzaman Kazi; Domenico Coppola; Abdissa Negassa; Linda Vahdat; Tianhong Li; Christine Pellegrino; Susan Fineberg; Pam Munster; Mokenge Malafa; David Lee; Shira Hoschander; Una Hopkins; Dawn Hershman; John J Wright; Celina G Kleer; Sofia D Merajver; Said M Sebti
Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(8):2942-8.
2009: Tianhong Li; P J Christos; Joseph A Sparano; Dawn Hershman; S Hoschander; K O'Brien; J J Wright; Linda Vahdat
Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):642-7.
2009: Dawn Hershman; Theresa H. Shao
Anthracycline cardiotoxicity after breast cancer treatment.
Oncology (Williston Park, N.Y.) 2009;23(3):227-34.
2009: Dawn Hershman; Christina Cho; Katherine D Crew
Management of complications from estrogen deprivation in breast cancer patients.
Current oncology reports 2009;11(1):29-36.
2008: Carol Magai; Nathan Consedine; Brenda A Adjei; Dawn Hershman; Alfred I Neugut
Psychosocial influences on suboptimal adjuvant breast cancer treatment adherence among African American women: implications for education and intervention.
Health education & behavior : the official publication of the Society for Public Health Education 2008;35(6):835-54.
2008: Dawn Hershman; Donald J McMahon; Katherine D Crew; Serge Cremers; Dinaz Irani; Gina Cucchiara; Lois Brafman; Elizabeth Shane
Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4739-45.
2008: Victor R Grann; Elad Ziv; Cecil K Joseph; Alfred I Neugut; Ying Wei; Judith S Jacobson; Marshall S Horwitz; Natalie Bowman; Kenneth Beckmann; Dawn Hershman
Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean.
British journal of haematology 2008;143(2):288-93.
2008: Victor R Grann; Natalie Bowman; Cecil Joseph; Ying Wei; Marshall S Horwitz; Judith S Jacobson; Regina P Santella; Dawn Hershman
Neutropenia in 6 ethnic groups from the Caribbean and the U.S.
Cancer 2008;113(4):854-60.
2008: Dawn Hershman; Alfred I Neugut
Anthracycline cardiotoxicity: one size does not fit all!
Journal of the National Cancer Institute 2008;100(15):1046-7.
2008: Dawn Hershman; Russell McBride; Andrew Eisenberger; Wei-Yann Tsai; Victor R Grann; Judith S Jacobson
Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3159-65.
2008: Dawn Hershman
Getting a grip on aromatase inhibitor-associated arthralgias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3120-1.
2008: Abby B Siegel; Russell B McBride; Hashem B El-Serag; Dawn Hershman; Robert S Brown; Lydia Zablotska; Alfred I Neugut
The risk of hepatocellular carcinoma in patients with previous malignancy.
Cancer investigation 2008;26(5):511-5.
2008: Adi Cohen; Jessica B Fleischer; Mariko K Johnson; Ijeoma N Brown; Andrew K Joe; Dawn Hershman; Donald J McMahon; Shonni J Silverberg
Prevention of bone loss after withdrawal of tamoxifen.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2008;14(2):162-7.
2008: Dawn Hershman; Donna Buono; Russell McBride; Wei-Yann Tsai; Kathie-Ann Joseph; Victor R Grann; Judith S Jacobson
Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer.
Journal of the National Cancer Institute 2008;100(3):199-206.
2008: Elizabeth L Kaufman; Judith S Jacobson; Dawn Hershman; Manisha Desai; Alfred I Neugut
Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):392-8.
2008: Abby B Siegel; Russell McBride; Hashem B El-Serag; Dawn Hershman; Robert S Brown; John F Renz; Jean Emond; Alfred I Neugut
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002.
The American journal of gastroenterology 2008;103(1):120-7.
2007: X Wang; Dawn Hershman; Julian A Abrams; Daniel L Feingold; Victor R Grann; Judith S Jacobson; Alfred I Neugut
Predictors of survival after hepatic resection among patients with colorectal liver metastasis.
British journal of cancer 2007;97(12):1606-12.
2007: Katherine D Crew; Jillian L Capodice; Heather Greenlee; Arlyn Apollo; Judith S Jacobson; George Raptis; Kimberly Blozie; Alex Sierra; Dawn Hershman
Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients.
Journal of cancer survivorship : research and practice 2007;1(4):283-91.
2007: Russell McBride; Dawn Hershman; Wei-Yann Tsai; Judith S Jacobson; Victor R Grann; Alfred I Neugut
Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.
Cancer 2007;110(6):1201-8.
2007: Clare Taylor; Dawn Hershman; Nina Shah; Nicole Suciu-Foca; Daniel P Petrylak; Robert N Taub; Linda Vahdat; Bin Cheng; Mark D Pegram; Keith L Knutson; Raphael Clynes
Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(17):5133-43.
2007: Katherine D Crew; Heather Greenlee; Jillian Capodice; George Raptis; Lois Brafman; Deborah Fuentes; Alex Sierra; Dawn Hershman
Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3877-83.
2007: Vicki A Morrison; Mitchell D Wong; Dawn Hershman; Luis T Campos; Beiying Ding; Jennifer Malin
Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practices.
Journal of managed care pharmacy : JMCP 2007;13(4):337-48.
2007: John J Doyle; Alfred I Neugut; Judith S Jacobson; Jian Wang; Russell McBride; Alison Grann; Victor R Grann; Dawn Hershman
Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients.
International journal of radiation oncology, biology, physics 2007;68(1):82-93.
2007: Alfred I Neugut; Benjamin Lebwohl; Dawn Hershman
Cancer chemoprevention: how do we know what works?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1461-2.
2007: Katherine D Crew; Alfred I Neugut; Xiaoyan Wang; Judith S Jacobson; Victor R Grann; George Raptis; Dawn Hershman
Racial disparities in treatment and survival of male breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(9):1089-98.
2007: Dawn Hershman; Alfred I Neugut; Judith S Jacobson; Jian Wang; Wei-Yann Tsai; Russell McBride; Charles L Bennett; Victor R Grann
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Journal of the National Cancer Institute 2007;99(3):196-205.
2007: Carol Magai; Nathan Consedine; Alfred I Neugut; Dawn Hershman
Common psychosocial factors underlying breast cancer screening and breast cancer treatment adherence: a conceptual review and synthesis.
Journal of women's health (2002) 2007;16(1):11-23.
2006: Dawn Hershman; Michael J. Hall; Xiaoyan Wang; Judith S Jacobson; Russell McBride; Victor R Grann; Alfred I Neugut
Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Cancer 2006;107(11):2581-8.
2006: Victor R Grann; Dawn Hershman; Judith S Jacobson; Wei-Yann Tsai; Jian Wang; Russell McBride; Nandita Mitra; Michael L Grossbard; Alfred I Neugut
Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma.
Cancer 2006;107(7):1530-41.
2006: Dawn Hershman; Xiaoyan Wang; Russell McBride; Judith S Jacobson; Victor R Grann; Alfred I Neugut
Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women.
Breast cancer research and treatment 2006;99(3):313-21.
2006: Dawn Hershman; Xiaoyan Wang; Russell McBride; Judith S Jacobson; Victor R Grann; Alfred I Neugut
Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival.
International journal of radiation oncology, biology, physics 2006;65(5):1353-60.
2006: Joseph A Sparano; Stacy Moulder; Aslamuzzaman Kazi; Linda Vahdat; Tianhong Li; Christine Pellegrino; Pamela N Munster; Mokenge Malafa; David Lee; Shira Hoschander; Una Hopkins; Dawn Hershman; John J Wright; Said M Sebti
Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3013-8.
2006: Alfred I Neugut; Matthew J Matasar; Xiaoyan Wang; Russell McBride; Judith S Jacobson; Wei-Yann Tsai; Victor R Grann; Dawn Hershman
Duration of adjuvant chemotherapy for colon cancer and survival among the elderly.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2368-75.
2006: Kristin Anderson; Judith S Jacobson; Daniel F Heitjan; Joshua Graff Zivin; Dawn Hershman; Alfred I Neugut; Victor R Grann
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.
Annals of internal medicine 2006;144(6):397-406.
2006: Xiaoyan Wang; Dawn Hershman; Alfred I Neugut
Using machine learning, general regression, and Cox proportional hazards regression to predict the effectiveness of treatment in patients with breast cancer.
AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium 2006;():1133.
2006: Judith S Jacobson; Victor R Grann; Dawn Hershman; Andrea B Troxel; Huiling Li; Alfred I Neugut
Breast biopsy and race/ethnicity among women without breast cancer.
Cancer detection and prevention 2006;30(2):129-33.
2006: Amy D Tiersten; M Selleck; Daniel H Smith; I Wertheim; Eliaz Kaufman; Dawn Hershman; Linda Vahdat; David G Savage; R B MacArthur; Charles Hesdorffer
Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(1):57-64.
2006: Victor R Grann; Andrea B Troxel; Naseem Zojwalla; Dawn Hershman; Sherry Glied; Judith S Jacobson
Regional and racial disparities in breast cancer-specific mortality.
Social science & medicine (1982) 2006;62(2):337-47.
2005: John J Doyle; Alfred I Neugut; Judith S Jacobson; Victor R Grann; Dawn Hershman
Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8597-605.
2005: Sherri Sheinfeld Gorin; Julia Heck; Steven Albert; Dawn Hershman
Treatment for breast cancer in patients with Alzheimer's disease.
Journal of the American Geriatrics Society 2005;53(11):1897-904.
2005: Dawn Hershman; Russell McBride; Judith S Jacobson; Lois Lamerato; Kevin Roberts; Victor R Grann; Alfred I Neugut
Racial disparities in treatment and survival among women with early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6639-46.
2005: Victor R Grann; Judith S Jacobson; Andrea B Troxel; Dawn Hershman; Julie Karp; Christa Myers; Alfred I Neugut
Barriers to minority participation in breast carcinoma prevention trials.
Cancer 2005;104(2):374-9.
2005: Kerin B Adelson; Charles L Loprinzi; Dawn Hershman
Treatment of hot flushes in breast and prostate cancer.
Expert opinion on pharmacotherapy 2005;6(7):1095-106.
2005: Victor R Grann; Andrea B Troxel; Naseem J Zojwalla; Judith S Jacobson; Dawn Hershman; Alfred I Neugut
Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
Cancer 2005;103(11):2241-51.
2005: Inna Postolov; Michael J Rasiej; Dawn Hershman; Arthur P Hays; John H M Austin
Thoracoabdominal muscular enlargement in dermatomyositis: CT visualization.
AJR. American journal of roentgenology 2005;184(3 Suppl):S91-3.
2005: Katherine D Crew; Michael H Cohen; Daniel H Smith; Amy D Tiersten; Nikki Feirt; Dawn Hershman
Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literature.
Gynecologic oncology 2005;96(1):235-40.
2004: Dawn Hershman; Judith S Jacobson; Russell McBride; Nandita Mitra; Vijaya Sundararajan; Victor R Grann; Alfred I Neugut
Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer.
Gynecologic oncology 2004;94(2):540-9.
2004: Dawn Hershman; Rashmi Narayanan
Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer.
Current oncology reports 2004;6(4):277-84.
2004: Amy D Tiersten; Meredith J Selleck; Dawn Hershman; D Smith; Edward E Resnik; Andrea B Troxel; Lois Brafman; Laureen Shriberg
Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma.
Gynecologic oncology 2004;92(2):635-8.
2004: Dawn Hershman; Aaron T Fleischauer; Judith S Jacobson; Victor R Grann; Vijaya Sundararajan; Alfred I Neugut
Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study.
Gynecologic oncology 2004;92(1):293-9.
2003: Dawn Hershman; Mitchell Weinberg; Zachary Rosner; Karenza Alexis; Amy D Tiersten; Victor R Grann; Andrea B Troxel; Alfred I Neugut
Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer.
Journal of the National Cancer Institute 2003;95(20):1545-8.
2002: Victor R Grann; Judith S Jacobson; Dustin Thomason; Dawn Hershman; Daniel F Heitjan; Alfred I Neugut
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2520-9.
2002: Vijaya Sundararajan; Dawn Hershman; Victor R Grann; Judith S Jacobson; Alfred I Neugut
Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):173-8.
2002: Dawn Hershman; Vijaya Sundararajan; Judith S Jacobson; Daniel F Heitjan; Alfred I Neugut; Victor R Grann
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):9-16.
2000: Victor R Grann; Judith S Jacobson; William Whang; Dawn Hershman; Daniel F Heitjan; Karen Antman; Alfred I Neugut
Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
The cancer journal from Scientific American 2000;6(1):13-20.
1995: Dawn Hershman; P A Simonoff; W H Frishman; F Paston; M K Aronson
Drug utilization in the old old and how it relates to self-perceived health and all-cause mortality: results from the Bronx Aging Study.
Journal of the American Geriatrics Society 1995;43(4):356-60.